» Articles » PMID: 22367266

Characterization of Effector Memory CD8+ T Cells in the Synovial Fluid of Rheumatoid Arthritis

Overview
Journal J Clin Immunol
Publisher Springer
Date 2012 Feb 28
PMID 22367266
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known about the cellular characteristics of CD8(+) T cells in rheumatoid arthritis (RA). We addressed this by investigating whether the frequency of the CD8(+) T cell subsets and their phenotypic characteristics are altered in the peripheral blood and synovial fluid (SF) from patients with RA. In this study, CD8(+) T cells, mainly CD45RA(-) effector memory (EM) CD8(+) T cells, were increased significantly in the SF, but not in the peripheral blood from RA patients, compared with healthy controls. The synovial EM CD8(+) T cells were activated phenotypes with high levels of CD80, CD86, and PD-1, and had a proliferating signature in vivo upon Ki-67 staining, whereas the Fas-positive cells were prone to apoptosis. In addition, EM CD8(+) T cells in the SF were less cytotoxic, as they expressed less perforin and granzyme B. In particular, the proportions of synovial fluid mononuclear cells that were CCR4(+)CD8(+) T cells and IL-4-producing CD8(+) T cells (i.e., Tc2 cells) were significantly higher than those in peripheral blood mononuclear cells of patients with RA and healthy controls. In addition, the number of IL-10-producing CD8(+) suppressor T (Ts) cells increased significantly in the SF of RA patients. Especially, CD8(+) T cells were inversely correlated with disease activity. These findings strongly suggest that EM CD8(+) T cells in the SF are increased, likely because of inflammation, and they may be involved in modulating inflammation, thereby affecting the development and progression of RA.

Citing Articles

Single-cell characterisation of tissue homing CD4 + and CD8 + T cell clones in immune-mediated refractory arthritis.

Bhattacharya D, Theodoropoulos J, Nurmi K, Juutilainen T, Eklund K, Koivuniemi R Mol Med. 2024; 30(1):48.

PMID: 38594612 PMC: 11005137. DOI: 10.1186/s10020-024-00802-1.


NFIL3 contributes to cytotoxic T lymphocyte-mediated killing.

Douanne T, Strege K, Del Castillo Velasco-Herrera M, Rochussen A, Adams D, Griffiths G Open Biol. 2024; 14(2):230456.

PMID: 38412963 PMC: 10898977. DOI: 10.1098/rsob.230456.


Identification of potential ferroptosis key genes and immune infiltration in rheumatoid arthritis by integrated bioinformatics analysis.

Fan Y, Li Y, Fu X, Peng J, Chen Y, Chen T Heliyon. 2023; 9(11):e21167.

PMID: 37920499 PMC: 10618794. DOI: 10.1016/j.heliyon.2023.e21167.


Circulating CD8+ T Cell Subsets in Primary Sjögren's Syndrome.

Kudryavtsev I, Benevolenskaya S, Serebriakova M, Grigoryeva I, Kuvardin E, Rubinstein A Biomedicines. 2023; 11(10).

PMID: 37893153 PMC: 10604770. DOI: 10.3390/biomedicines11102778.


Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment.

Lowe K, Small A, Song Q, Hao L, Murray-Brown W, Proudman S Sci Rep. 2023; 13(1):2847.

PMID: 36801909 PMC: 9938264. DOI: 10.1038/s41598-023-29971-5.


References
1.
Inaoki M, Sato S, Shirasaki F, Mukaida N, Takehara K . The frequency of type 2 CD8+ T cells is increased in peripheral blood from patients with psoriasis vulgaris. J Clin Immunol. 2003; 23(4):269-78. DOI: 10.1023/a:1024584732614. View

2.
Austin L, Ozawa M, Kikuchi T, Walters I, Krueger J . The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1.... J Invest Dermatol. 1999; 113(5):752-9. DOI: 10.1046/j.1523-1747.1999.00749.x. View

3.
McInnes I, Schett G . Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007; 7(6):429-42. DOI: 10.1038/nri2094. View

4.
Alves N, Arosa F, van Lier R . IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J Immunol. 2005; 175(2):755-62. DOI: 10.4049/jimmunol.175.2.755. View

5.
Abe K, Takasaki Y, Ushiyama C, Asakawa J, Fukazawa T, Seki M . Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. J Clin Immunol. 1999; 19(1):58-66. DOI: 10.1023/a:1020566618980. View